The levels of bictegravir fall too much due to the presence of inducer effect of rifampin / rifabutin and predispose to the risk of HIV viral failure (see Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents: Drug-Drug Interactions); thus, interactions should always be checked before any new drug is started.